Mark Lee Barr, MD

Associate Professor of Surgery

Chair for the Department's Appointments, Promotion and Tenure Committee

Director of Cardiac Surgery Clearkship

Image of Mark Lee Barr, MD
Is this your profile? Click to edit

Overview

Dr. Mark L. Barr obtained his medical degree from Mount Sinai School of Medicine and completed 10 years of postgraduate residency at New York University and Columbia University, including a 2-year NIH-sponsored research fellowship in transplantation immunology. He is a tenured faculty member in the Department of Surgery and serves as Co-Director of the USC Transplantation Institute; Chair of the Department of Surgery Appointments, Promotions, and Tenure Committee; and Director of the Cardiothoracic Surgery Medical Student Clerkship. He has served as Chair of the UNOS Thoracic Transplantation Committee, as President of the International Society for Heart and Lung Transplantation (ISHLT), as Chair of the Thoracic Committee of the American Society of Transplant Surgeons (ASTS), and on the Board of Directors of the ISHLT, the ASTS, the American Society of Transplantation, and the Board of Directors of the OPTN / UNOS. Dr. Barr was the Chair of the Advisory Committee on Transplantation (ACOT) under the auspices of the Secretary of the Department of Health and Human Services during the 8 years of the Obama administration. He is an author / co-author on more than 150 peer-reviewed publications and book chapters in the fields of cardiothoracic surgery and heart and lung transplantation, has served on multiple scientific review boards for NIAID, NHLBI, and NCRR of the National Institutes of Health, and was a Deputy Editor of the American Journal of Transplantation for 15 years.

Publications

  • Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury. Ann Thorac Surg. 1998 Jul; 66(1):225-30.. View in PubMed
  • Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury. J Thorac Cardiovasc Surg. 1998 Mar; 115(3):631-6.. View in PubMed
  • Experience with living-donor lobar transplantation for indications other than cystic fibrosis. J Thorac Cardiovasc Surg. 1997 Dec; 114(6):917-21.. View in PubMed
  • Living donor lobar lung transplants and HLA matching: a preliminary report. Transplant Proc. 1997 Feb-Mar; 29(1-2):1418-9.. View in PubMed
  • A new organ preservation solution, Celsior, is superior to Euro-Collins and University of Wisconsin solutions in decreasing lung reperfusion injury. Transplant Proc. 1997 Feb-Mar; 29(1-2):1357-8.. View in PubMed
  • Living-donor lobar lung transplantation experience: intermediate results. J Thorac Cardiovasc Surg. 1996 Nov; 112(5):1284-90.. View in PubMed
  • Bilateral lobar transplantation utilizing living related donors. Artif Organs. 1996 Oct; 20(10):1110-1.. View in PubMed
  • Immunomodulation in transplantation with photopheresis. Artif Organs. 1996 Aug; 20(8):971-3.. View in PubMed
  • Safe application of diagnostic laparoscopy during biventricular assistance. Ann Thorac Surg. 1996 Feb; 61(2):735-7.. View in PubMed
  • Prophylactic photopheresis and effect on graft atherosclerosis in cardiac transplantation. Transplant Proc. 1995 Jun; 27(3):1993-4.. View in PubMed